The ROE as of December 2025 (TTM) for Advagene Biopharma Co., Ltd. (6709.TWO) is -34.85%

According to Advagene Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -34.85%. This represents a change of 44.75% compared to the average of -24.08% of the last 4 quarters.

Advagene Biopharma Co., Ltd. (6709.TWO) Historical ROE (quarterly & annually)

How has 6709.TWO ROE performed in the past?

The mean historical ROE of Advagene Biopharma Co., Ltd. over the last ten years is -46.91%. The current -34.85% ROE has changed -25.70% with respect to the historical average. Over the past ten years (40 quarters), 6709.TWO's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the June 2023 quarter at -54.77%.

Advagene Biopharma Co., Ltd. (6709.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of Advagene Biopharma Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Advagene Biopharma Co., Ltd. (6709.TWO) Average ROE

How has 6709.TWO ROE performed in the past?

The current ROE of Advagene Biopharma Co., Ltd. (6709.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Advagene Biopharma Co., Ltd. (6709.TWO) ROE vs. Peers

How is 6709.TWO’s ROE compared to its peers?

Advagene Biopharma Co., Ltd.’s ROE is greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-3.12%), greater than Genomics BioSci & Tech. Co.,Ltd. (-31.04%), greater than Sunny Pharmtech Inc. (-27.76%), less than Greenyn Biotechnology Co., Ltd (16.75%), greater than Meribank Biotech Co., Ltd (-5.56%), greater than Hcmed (-53.25%), greater than InnoPharmax Inc. (-18.51%), greater than Shangya Technology Co., Ltd. (-12.73%), greater than Enimmune corporation (-70.32%), greater than NaviFUS Corp. (-20.73%),

Build a custom stock screener for Advagene Biopharma Co., Ltd. (6709.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advagene Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advagene Biopharma Co., Ltd. (6709.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advagene Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.